|
gptkbp:instanceOf
|
gptkb:medical_device
|
|
gptkbp:alternativeTo
|
Heart transplant
|
|
gptkbp:approvedBy
|
gptkb:FDA
2004
|
|
gptkbp:canBe
|
Temporary
Permanent
Bridge to transplant
Destination therapy
|
|
gptkbp:category
|
Cardiovascular device
Implantable device
|
|
gptkbp:complication
|
gptkb:Stroke
Infection
Blood clot
|
|
gptkbp:cost
|
Hundreds of thousands of dollars
|
|
gptkbp:countryOfFirstImplant
|
gptkb:United_States
|
|
gptkbp:developedBy
|
gptkb:Paul_Winchell
gptkb:Robert_Jarvik
|
|
gptkbp:firstImplanted
|
1982
|
|
gptkbp:firstPatient
|
gptkb:Barney_Clark
|
|
gptkbp:lifespan
|
Several months to years
|
|
gptkbp:limitation
|
Limited mobility
Risk of device failure
|
|
gptkbp:maintenance
|
Regular medical follow-up
|
|
gptkbp:material
|
Titanium
Polyurethane
|
|
gptkbp:monitors
|
gptkb:cardiologist
Surgeon
|
|
gptkbp:notableModel
|
gptkb:Jarvik-7
gptkb:SynCardia_Total_Artificial_Heart
|
|
gptkbp:notRecommendedFor
|
Patients with irreversible organ failure
Patients with severe infection
|
|
gptkbp:patent
|
gptkb:Paul_Winchell
|
|
gptkbp:patentedYear
|
1963
|
|
gptkbp:provides
|
gptkb:battery
External power source
|
|
gptkbp:relatedTo
|
gptkb:Pacemaker
Ventricular assist device
|
|
gptkbp:requires
|
Anticoagulation therapy
Hospitalization for implantation
|
|
gptkbp:riskFactor
|
Bleeding
Immune response
Device malfunction
|
|
gptkbp:size
|
Similar to human heart
|
|
gptkbp:suitableFor
|
End-stage heart failure patients
|
|
gptkbp:surgeryType
|
Open-heart surgery
|
|
gptkbp:usedFor
|
Pumping blood
Replacing biological heart
|
|
gptkbp:usedIn
|
Cardiac surgery
|
|
gptkbp:weight
|
About 1 kg
|
|
gptkbp:bfsParent
|
gptkb:Peter_Gizzi
gptkb:Jonathan_Coulton
|
|
gptkbp:bfsLayer
|
7
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Artificial Heart
|